3
Announcements
Trials
Browse
Landscape
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Gynecologic
1
Conditions
Uterine Cervical Neoplasms
11
Prostatic Neoplasms
9
Uterine Neoplasms
2
Hyperthermia
2
Endometrial Neoplasms
2
Vulvar Neoplasms
1
Vaginal Neoplasms
1
Rhabdomyosarcoma
1
Recurrence
1
Ovarian Neoplasms
1
Neoplasms
1
Lung Neoplasms
1
Locally Advanced Cervical Adenocarcinoma
1
Head and Neck Neoplasms
1
Genital Neoplasms, Female
1
Esophageal Squamous Cell Carcinoma
1
Esophageal Neoplasms
1
Endometrial Clear Cell Adenocarcinoma
1
Directly Observed Therapy
1
Cervical Adenocarcinoma
1
Carcinoma, Renal Cell
1
Adenocarcinoma
1
Interventions
relacorilant
1
pembrolizumab
1
lenvatinib
1
Watchful Waiting
1
Transurethral Resection of Prostate
1
Therapeutic Touch
1
Surveys and Questionnaires
1
Surgical Procedures, Operative
1
Standard of Care
1
Radiotherapy
1
Pregnancy Tests
1
Human Papillomavirus DNA Tests
1
Drug Therapy
1
Colposcopy
1
Brachytherapy
1
Biopsy
1
Bevacizumab
1
Acetic Acid
1
130-nm albumin-bound paclitaxel
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Recruiting
×
Genital Neoplasms, Female
×
Brachytherapy
×
Clear all
NCT05242861
2022-02-16
RetroBT
Zhejiang Cancer Hospital
Recruiting
300 enrolled